EXOFLO
Live / Allowed — Notice of allowance issued (as of 12 Aug 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Oct 2018 filing date already counts against anyone who files later.
Record
- Serial number
- 88165407
- Mark type
- Stylized text
- Filed
- 23 Oct 2018
- Published for opposition
- 04 Jun 2019
- Attorney of record
- AARON D. HENDELMAN
Goods and services
- Class 005 — Pharmaceuticals: Medical products and therapeutic applications for regenerative medicine, cosmetics, and tissue regeneration, namely, human allograft tissue in the form of amniotic patches, amniotic fluid, and purified exosomes, all for the regenerative treatment of wounds, burns, and soft tissue injuries
Owner
- Direct Biologics LLC, St. Louis, MO, US
- Direct Biologics LLC, St. Louis, MO, US
Prosecution history
- 23 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jul 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 03 Jul 2025 — OPPOSITION TERMINATED NO. 999999
- 03 Jul 2025 — OPPOSITION DISMISSED NO. 999999
- 02 Jan 2024 — ASSIGNED TO EXAMINER
- 27 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Oct 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Oct 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Jul 2019 — OPPOSITION INSTITUTED NO. 999999
- 02 Jul 2019 — OPPOSITION PAPERS RECEIVED AT TTAB
- 04 Jun 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2019 — PUBLISHED FOR OPPOSITION